5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 34.64▲ | 34.73▲ | 34.04▲ | 35.35▼ | 35.22▼ |
MA10 | 34.74▲ | 33.60▲ | 33.39▲ | 37.44▼ | 27.64▲ |
MA20 | 34.68▲ | 33.40▲ | 34.24▲ | 35.45▼ | 21.08▲ |
MA50 | 33.35▲ | 35.27▼ | 37.34▼ | 25.19▲ | 25.85▲ |
MA100 | 33.83▲ | 37.50▼ | 38.09▼ | 21.78▲ | 701.38▼ |
MA200 | 35.81▼ | 37.26▼ | 30.87▲ | 21.18▲ | 6,968.36▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.096▼ | 0.393▲ | 0.308▲ | -1.086▼ | 10.184▲ |
RSI | 57.752▲ | 54.539▲ | 47.899▼ | 54.658▲ | 44.469▼ |
STOCH | 31.754 | 83.940▲ | 54.232 | 28.312 | 70.756 |
WILL %R | -56.250 | -18.391▲ | -18.391▲ | -62.418 | -31.738 |
CCI | -21.815 | 87.431 | 75.065 | -119.872▼ | 80.801 |
RSI | $TNXP RSI(14) Crossed Above 50 | Set Alert |
Friday, June 13, 2025 11:59 AM
Tonix Pharmaceuticals (NASDAQ: TNXP) a fully-integrated biotechnology company with marketed products and late-stage development candidates, announced ...
|
Friday, June 13, 2025 04:30 AM
Tonix Pharmaceuticals' TNX-102 SL nears FDA approval for fibromyalgia with positive trials. Find out why we recommend buying TNXP stock before PDUFA.
|
Friday, June 13, 2025 04:10 AM
Appointment strengthens commercial strategy and governance as Tonix prepares for potential launch of TNX-102 SL for fibromyalgia this year CHATHAM, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- Tonix ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 32.01 | 35.57 | 31.63 | 34.75 | 454,158 |
13/06/25 | 33.50 | 34.6899 | 31.50 | 31.98 | 684,867 |
12/06/25 | 29.05 | 35.8465 | 29.00 | 34.54 | 1,338,885 |
11/06/25 | 38.00 | 38.7499 | 37.12 | 37.71 | 835,607 |
10/06/25 | 38.94 | 39.87 | 37.63 | 37.75 | 478,526 |
09/06/25 | 42.42 | 44.12 | 38.81 | 39.20 | 821,717 |
06/06/25 | 38.11 | 41.765 | 38.06 | 40.65 | 729,079 |
05/06/25 | 38.94 | 39.91 | 37.37 | 38.41 | 675,979 |
04/06/25 | 41.645 | 41.645 | 38.50 | 38.95 | 612,161 |
03/06/25 | 39.42 | 44.30 | 39.00 | 40.45 | 927,862 |
|
|
||||
|
|
||||
|
|